CLINICAL_TRIALS
trial_result
· 2019-04-10
Clinical Trial Update: Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks [Phase 3]
Summary
Phase 3 clinical trial comparing Cefalium® to Tylenol® for migraine treatment has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Migraine | Phase 3 | Status: SUSPENDED